EIM
CRBP icon

Essex Investment Management’s Corbus Pharmaceuticals CRBP Stock Holding History

Essex Investment Management’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-3,004
Closed -$626K – 485
2019
Q1 		$626K Buy
+3,004
New +$663K 0.09% 241

Other funds holding CRBP

EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Essex Investment Management's CRBP Position: Q2 2019 in Review

Essex Investment Management sold out of Corbus Pharmaceuticals (CRBP) in Q2 2019, closing a stake of 3,004 shares — an estimated $626K sold.

Essex Investment Management first reported a position in CRBP in Q1 2019 and held it in 1 quarter. The position peaked at $626K in Q1 2019. 103 funds tracked by Wall St. Rank hold CRBP as of Q2 2019.

  • Essex Investment Management reported no remaining Corbus Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Essex Investment Management sold 3,004 Corbus Pharmaceuticals shares in Q2 2019, an estimated $626K.
  • Essex Investment Management first reported a position in Corbus Pharmaceuticals in Q1 2019 and held it in 1 quarter.
  • Essex Investment Management's Corbus Pharmaceuticals position peaked at $626K in Q1 2019.
  • 103 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2019.

Based on Essex Investment Management's 13F filing for Q2 2019, filed 15 Aug 2019.